eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-HIK.L-Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC HIK.L

1,727.40p-14.98(-0.86%)(1D)
Delayed prices by LSEin GBX
Invest in Hikma Pharmaceuticals PLC
Today
Create an eToro account to buy HIK.L stock on a secure, user-friendly, multi-asset trading platform.
Buy Hikma Pharmaceuticals PLC
Buy Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC HIK.L
About Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a global pharmaceutical company focused on developing, manufacturing, and marketing a diverse range of branded and generic medicines. Its primary aim is to make high-quality, essential pharmaceutical products accessible to patients across international markets.

Operating within the pharmaceutical sector, Hikma Pharmaceuticals PLC concentrates on three core areas: injectables, branded products, and generics. The company strives to improve health outcomes by providing critical medications that address diverse patient needs worldwide.

Monitor the HIK.L share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
VIEW MORE   

HIK.L Stock Price Chart

‎-10.64‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Hikma Pharmaceuticals PLC share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Hikma Pharmaceuticals PLC share price today is 1,727.40p, reflecting a ‎-0.86‎% change over the last 24 hours and ‎-3.14‎% over the past week. The current market capitalization of HIK.L is 3.8Bp with an average volume in the last three months of 520041.6. The stock has a P/E ratio of 13.3 and a dividend yield of 0.04%. With the stock’s beta sitting at -0.07
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
3.8Bp

Day’s Range
i
Shows the high and low prices of the day.
1714.42p - 1755.36p

52W Range
i
Shows the high and low prices of the last year.
1684.46p - 2352.46p

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
520041.6

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
13.3

Revenue
i
The total income generated by this company’s goods and services last year.
2.49Bp

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0.64p (0.04%)

Prev Close
i
The final price of this asset at the end of the last trading day.
1727.4p

EPS
i
A company’s total earnings divided by the number of shares it has issued.
1.3p

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-0.07

What Is Hikma Pharmaceuticals PLC?
Hikma Pharmaceuticals PLC is a global pharmaceutical company focused on developing, manufacturing, and marketing a diverse range of branded and generic medicines. Its primary aim is to make high-quality, essential pharmaceutical products accessible to patients across international markets.

Operating within the pharmaceutical sector, Hikma Pharmaceuticals PLC concentrates on three core areas: injectables, branded products, and generics. The company strives to improve health outcomes by providing critical medications that address diverse patient needs worldwide.

Monitor the HIK.L share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

How can I buy Hikma Pharmaceuticals PLC stocks?

To purchase Hikma Pharmaceuticals PLC:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Hikma Pharmaceuticals PLC (HIK.L) page and place an order to buy Hikma Pharmaceuticals PLC.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Hikma Pharmaceuticals PLC
Invest in Hikma Pharmaceuticals PLC
Today
Create an eToro account to buy HIK.L stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of HIK.L is 1,727.40p.
Analysts offer forecasts for Hikma Pharmaceuticals PLC based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Hikma Pharmaceuticals PLC is 3.8Bp
Scroll to top